DHG Pharmaceutical Joint Stock Company

HOSE:DHG Stock Report

Market Cap: ₫13.1t

DHG Pharmaceutical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Osamu Fujimori

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure2.2yrs
Board average tenure5.8yrs

Recent management updates

Recent updates

CEO

Osamu Fujimori

less than a year

Tenure

Mr. Osamu Fujimori is Chief Executive Officer of DHG Pharmaceutical Joint Stock Company from January 1, 2025.

Leadership Team

NamePositionTenureCompensationOwnership
Toshiyuki Ishii
General Director2.2yrs₫5.44bno data
Osamu Fujimori
Chief Executive Officerless than a yearno datano data
Huan Ho
Chief Accountant8.7yrsno data0.00071%
₫ 93.0m
Y. Vo Kim
Technology Directorno datano datano data
Loan Duong
Finance & IR Managerno datano datano data
Gam Thi Tran
Secretaryno datano datano data

2.2yrs

Average Tenure

Experienced Management: DHG's management team is considered experienced (2.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Toshiyuki Ishii
General Director1.9yrs₫5.44bno data
Jun Kuroda
Non-Executive Director8.6yrs₫646.35mno data
Ha Thi Dang
Chairwoman7.7yrs₫850.00mno data
Hung Do
Independent Director5.8yrs₫765.00mno data
Maki Kamijo
Non-Executive Director5.8yrs₫595.00mno data
Hung Truong
Independent Directorless than a year₫410.77mno data

5.8yrs

Average Tenure

59yo

Average Age

Experienced Board: DHG's board of directors are considered experienced (5.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/23 08:18
End of Day Share Price 2025/03/21 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DHG Pharmaceutical Joint Stock Company is covered by 8 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hang Thi VuCGS International
Kien GiangFPT Securities
Michael KokalariMaybank Investment Bank Berhad